In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Abstract: In Part II, both skin and proximity effects in multisolid and hollow conductor arrays are accurately predicted over an ultrawide frequency range. This is accomplished through the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results